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Background: A preparation method for quantification of bacteria in tissues is obligatory to reduce tissue mass,
concentrate the target, purify, remove inhibitory substances and to achieve constant target recovery rates. No
preparation method has been available until now for a high mass of tissue applicable for routine use and analytical
veterinary diagnostics.
Results: This study describes an easy-to-use tissue preparation protocol to quantify Gram-positive bacteria from a
large volume of tissue matrix. A previously published sample preparation method (Matrix-Lysis) from food science
was successfully adapted for clinical use on tissues from pigs, including cerebrum, spinal cord, lung, liver, ileum,
colon, caecum, kidney and muscle tissue. This tissue preparation method now permits quantification of pathogens
from 5 g of organic matrix, which is a 20–200 fold increase by weight compared to other methods. It is based on
solubilization of the sample matrix with either a chaotrope plus detergent or divalent salts as solubilization agents.
The method was designed as a modular system, offering the possibility to change lysis buffers, according to tissue
solubilization characteristics and the intended detection method (molecular or culture). Using Listeria monocytogenes
as model organism, viable cell quantification or DNA extraction and quantitative real-time PCR were performed after
Matrix-Lysis to determine recovery rates and detection limit (LOD). The adapted Matrix-Lysis protocol resulted in high
recovery rates (mean value: 76% ± 39%) for all tested organs, except kidney, and recovery was constant over 5 log
scales for all tested buffer systems. The LOD for Matrix-Lysis with subsequent plate count method (PCM) was as low as
1 CFU/5 g, while for qPCR based detection the LOD was 102 bacterial cell equivalents (BCE)/5 g for two buffer systems.
Conclusions: This tissue preparation is inexpensive and can be easily used for routine and analytical veterinary
diagnostics. Inoculation studies or hazard assessments can profit from this tissue preparation method and it is
anticipated that this study will be a valuable source for further research on tissue preparation strategies.
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Molecular tools for detecting, analyzing and quantifying
specific microorganisms are well established in modern
analytical diagnostics. The rising demand for fast quanti-
fication tools for pathogens has led to a tremendous
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unless otherwise stated.molecular biological techniques, such as quantitative
real-time PCR (qPCR) [1-3]. Real-time PCR is a very
efficient and accurate quantification technique with a
potential limit of detection (LOD) of three target
copies per PCR reaction, assuming Poisson distribu-
tion and a confidence level of 95% [4].
PCR assays have been published for almost all known
bacterial pathogens, targeting resistance or virulence
genes or conserved regions [5,6]. However, prior methods
that have to be used before qPCR assays, such as tissue
preparation or DNA extraction, are disregarded in most
cases. In analytical diagnostics, qPCR is mostly applied
after direct DNA extraction using a small amount of tissuetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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propriate tissue preparation strategy, where target cells are
extracted, concentrated and purified from the surrounding
matrix [7-10]. This approach can result in false quantifica-
tion of bacterial targets and, even more importantly, false
negatives in qPCR [2,11]. The main reasons for these
complications are concentration and irregular distribution
of target cells in tissues: when skipping tissue preparation
and directly processing a small quantity via DNA extrac-
tion, pathogens that are not uniformly distributed in the
tissue might be over- or underestimated. This can also be
fostered by heterogeneity of the tissue matrix, by patho-
logical tissue alterations or by a low number of target
microorganisms. Therefore, a representative quantity of
tissue and subsequent tissue preparation to concentrate
target cells are essential for precise quantification.
Besides qPCR, other methods can benefit from the
abilities of a tissue preparation method to reduce the tis-
sue matrix and concentrate target bacteria. For example,
plating microorganisms is a common approach to quali-
tative pathogen detection, but where enrichment steps
are necessary prior to detection, quantification becomes
impossible. A high background flora on plates might
strongly influence the growth of target organisms. This, as
well as the methodological problem of low-occurrence of
pathogens, is frequently discussed in the literature [12-14].
A direct plating approach, to quantify low numbers of
target cells, has not been used in clinical diagnostics
until now. However, this is possible using an adequate
tissue preparation method to concentrate target cells
prior to plating.
In general, pathogen quantification is always a multi-
step process, which is also referred to as an analytical
chain. This chain can be subdivided into links comprising
“sampling, tissue preparation, and plating” or “sampling,
tissue preparation, DNA extraction/isolation, and target
amplification/detection” [15]. Each individual link within
such a chain is equally important and this necessitates that
they should be individually controlled. A failure at any one
link in the chain falsifies the final result. Another conse-
quence of such an analytical chain is that every upstream
method constitutes a bottleneck for the subsequent
method. Targets lost early cannot be “recovered” later. It
therefore becomes clear that the initial links within an
analytical chain, in this case pre-treatment and tissue
preparation, are key in analyses and that they are as
important as later DNA-extraction or target amplification.
Implementation of a cost-effective, robust and easy-to-
use tissue preparation method prior to pathogen detec-
tion remains challenging in clinical applications, and is
still problematic in nucleic acid testing [16]. Until now
no reliable tissue preparation method for routine appli-
cations and analytical veterinary diagnostics has been
available. Possible solutions to these difficulties couldcome from other disciplines. A scientific field that faces
the same challenges as clinical diagnostics, namely the
need to detect pathogens in a large quantity of a com-
plex matrix, qualitatively, and especially quantitatively, is
food safety.
In food microbiology, requirements for a food sample
preparation method are now well defined and can be
specified as follows: i) reduction of matrix size for down-
stream steps without loss of target bacteria, ii) concen-
tration of the target, iii) purification and removal of
inhibitory substances, and iv) a low detection limit and
constant recovery rate of the target [17]. Many sample
preparation techniques have been described in the
literature that aim to concentrate target cells and purify
them from extraneous matrices: immunological methods
based on magnetic bead separation [18] or high gradient
separation [19], physical methods based on filtration,
flotation or gradient centrifugation [20,21], adsorptive
methods using activated carbon for separation of target
cells [22] and methods based on electrophoresis or
enzymatic digestion [22,23]. Due to limitations of these
methods, including high costs, low throughput, complex
procedures or the need for minimum, non-representative
tissue quantities [24], these methods have largely been
abandoned in analytical veterinary diagnostics. It is un-
likely that any one of these aforementioned strategies can
cover all requirements for organs, including their patho-
logical variants and species-specific differences.
However, a promising sample preparation method that
can overcome these problems is Matrix-Lysis, which was
initially developed in food science for application with
dairy and meat products [25]. The Matrix-Lysis protocol
includes solubilization of the food matrix, concentration
and purification of contaminant bacteria through wash-
ing and centrifugation steps. The method is economical,
rapid and the LOD for food matrices has been described
to be lower than 10 CFU/g [25-27]. In particular,
Matrix-Lysis is a modular system with interchangeable
lysis buffers. The lysis buffer is responsible for adequate
solubilization of the matrix. If the matrix is well solubi-
lized, the size of the remaining pellet (consisting of both
bacteria and some tissue residues) is small, as most of
the tissue is dissolved. This is important as only small
pellets (<350 mg) can be processed further in a DNA ex-
traction system; otherwise the background DNA is too
high or the column of the DNA extraction system be-
comes obstructed. Interchangeability of the lysis buffers
permits adaptations, alterations and structural changes,
depending upon the matrix components, which could be
highly advantageous for clinical applications.
The aim of this study was therefore to apply and adapt
the Matrix-Lysis food sample preparation method to
different healthy organs and to introduce it as a tissue
preparation method for routine use and analytical
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detection limit of <100 BCE (bacterial cell equivalents)/g,
which is claimed to be required urgently in diagnostics
[16]. A method such as this is anticipated to improve
quantification processes in veterinary clinical research,
microbiology and post-mortem diagnostics. The study or-
gans were taken from healthy slaughtered pig carcasses
and acted as models for tissues originating from a variety
of mammalian species. Furthermore, detection limits for
the analytical chains “Matrix-Lysis, DNA-extraction and
qPCR”, and “Matrix-Lysis and subsequent plate count
method (PCM)” were defined. For spiking experiments,
Listeria (L.) monocytogenes was used as a model Gram-
positive organism.Results
Solubilization of clinical tissues and adaptation of the
Matrix-Lysis protocol
The Matrix-Lysis protocol was applied as published [26],
for testing the solubilization capability of two different
lysis buffers (8 M urea + 1% SDS; 2 M MgCl2 with
optional 1% Lutensol AO-07) on clinical tissues. The
solubilization capability was considered sufficient if the
remaining pellet after Matrix-Lysis was small enough for
downstream analysis. The threshold for the pellet size
was set at <350 mg. This corresponded to a pellet mass
of 7% compared to the mass utilized (5 g). A remaining
pellet size >7% was considered insufficiently solubilized.
Six out of nine clinical tissues were solubilized suffi-
ciently using the 8 M urea + 1% SDS lysis buffer. Insuffi-
cient lysis was achieved with lung, ileum and caecum.
Only three sufficient tissue lysates were obtained using
the 2 M MgCl2 lysis buffer. Liver, colon, kidney, lung,
ileum and muscle tissue produced pellets more than 7%
volume. The resultant pellet size from five tissues was
considered sufficient with the 1% Lutensol AO-07 added
to the 2 M MgCl2 lysis buffer. Liver, lung, ileum and
caecum could not be lysed sufficiently. Details about the
remaining pellet sizes are listed in Table 1.
Matrix-Lysis was repeated making use of the adapted
protocol (this study) to achieve more efficient tissue
lysis. An additional homogenization step after incubation
in lysis buffer was introduced and pre-warmed buffers
(protease buffer, lysis buffer and washing buffer) further
enhanced the solubilization process. The complete proto-
col established for clinical tissue is shown in Figure 1. All
tissues that were insufficiently lysed were tested again with
the established Matrix-Lysis protocol for clinical tissue.
The 8 M urea + 1% SDS lysis buffer resulted in sufficient
pellet sizes for all tissues, except lung. The 2 M MgCl2
lysis buffer was insufficient for lung and muscle tissues.
However, all tissues were solubilized sufficiently using the
2 M MgCl2 + 1% Lutensol AO-07 lysis buffer (Table 1).Artificial contamination experiments
Results of artificial contamination experiments for nine
different tissues are presented in Figure 2. Matrix -Lysis,
including the lysis buffer 2 M MgCl2 + 1% Lutensol, was
used and subsequently DNA extraction and qPCR were
performed for quantification. The tissues were spiked
with approximately 105 BCE/g. Overall recovery after
Matrix-Lysis was within 1 log10 unit for all nine tissues.
Unexpectedly, kidney tissue showed consistently lower
recovery rates (15% ± 7.9%) compared with other organs.
Mean recovery rate of target cells from organs, exclud-
ing kidney, was 76% ± 39%. To test the stability of recov-
ery rates through dilution series, extended artificial
contamination experiments over a five log10 dilution
series were performed with 5 g of cerebral tissue. Lysis
buffers used for Matrix-Lysis were 8 M urea + 1% SDS
and 2 M MgCl2 + 1% Lutensol and qPCR was used for
quantification. The amount of inocula ranged from
102-106 BCE/g tissue. With 8 M urea + 1% SDS buffer for
Matrix-Lysis, mean recovery rate was 32.5% (R2 = 0.99).
When the buffer was based on 2 M MgCl2 + 1% Lutensol,
mean recovery was 104.3% (R2 = 0.99).
The PCM method (ALOA agar) was used for quantifi-
cation of the 2 M MgCl2 lysis buffer-treated samples,
since 2 M MgCl2 is known to preserve the viability of
bacteria and this makes a plating approach possible. The
amount of inocula ranged from 101- 105 CFU/g. The
mean recovery rate for L. monocytogenes using Matrix-
Lysis, with a lysis buffer based on 2 M MgCl2, was 96.1%
(R2 = 0.99) after PCM.
LOD for PCM
The major advantage of Matrix-Lysis tissue preparation
lies in its efficiency and robustness to recover and con-
centrate as few as one bacterial cell from a large sample
mass (5 g) into a pellet small enough for subsequent
molecular and microbiological detection methods. To
determine if tissue preparation with Matrix-Lysis is as
efficient at low bacteria numbers as it is with higher
numbers, tests were performed to determine both the
LOD and reproducibility of the Matrix-Lysis tissue
preparation method. This was performed by testing
triplicates of low bacteria counts (between 0.5 and
50 CFU/5 g tissue; Table 2). Tests were performed
using PCM as the detection method because only a
fraction (in this study 1/20) of the total sample is used
for the actual detection reaction with a qPCR detection
system after DNA-extraction; inevitably resulting in a
higher LOD [28].
Positive and negative controls performed as expected.
The average number of CFU incorporated into each 5 g
sample was obtained on TSA + Y agar. The number of
CFU after Matrix-Lysis was determined by subdividing
the remaining pellet into five equal parts and plating
Table 1 Remaining pellet size (% wet weight) after performing Matrix-Lysis protocol with different lysis buffers and
tissues
8 M urea + 1% SDS (%) 2 M MgCl2 + 1% Lutensol (%) 2 M MgCl2 (%)
Mayrl et al. (2009) [26] This study Mayrl et al. (2009) [26] This study Mayrl et al. (2009) [26] This study
Cerebrum 1.1 ± 0.12 n.e. 2.9 ± 0.05 n.e. 1.4 ± 0.20 n.e.
Spinal cord 1.3 ± 0.11 n.e. 2.5 ± 0.17 n.e. 1.7 ± 0.25 n.e.
Liver 1.8 ± 0.31 n.e. 7.2 ± 0.24 4.3 ± 0.10 8.2 ± 0.21 3.9 ± 0.04
Colon 2.7 ± 0.16 n.e. 9.8 ± 0.03 2.2 ± 0.13 5.2 ± 0.80 n.e.
Kidney 1.0 ± 0.00 n.e. 7.2 ± 0.43 4.1 ± 0.03 3.4 ± 0.25 n.e.
Lung 13.2 ± 0.20 9.8 ± 0.121 23 .0 ± 0.18 7.3 ± 0.171 56.0 ± 0.35 6.6 ± 0.43
Ileum 9.8 ± 0.30 2.6 ± 0.11 47.0 ± 0.09 2.9 ± 0.05 52.0 ± 0.20 3.1 ± 0.05
Caecum 12.1 ± 0.15 3.8 ± 0.10 3.7 ± 0.04 n.e. 12.0 ± 0.24 4.3 ± 0.10
Muscle 1.7 ± 0.08 n.e. 26.7 ± 0.47 11 .0 ± 0.311 5.9 ± 0.02 n.e.
1lysis efficiency was too low for sufficient solubilization; these pellets could not be used for further downstream analyses.
n.e. = not examined (the protocol of Mayrl et al. (2009) [26] revealed sufficient solubilization).
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for L. monocytogenes from 5 g of cerebrum tissue with
Matrix-Lysis + PCM was determined to be as low as one
single cell and the efficiency of Matrix-Lysis tissue prep-
aration at low levels was equal to that determined at
higher bacterial levels (Table 2).
Discussion
Detection, and especially quantification, of pathogens
present in very low numbers in a large clinical sample
requires technological solutions adapted to the respect-
ive tissue matrix [24]. It is essential for any molecular
diagnostic to realize that the detection reaction is indeed
only the last in a series of sequentially applied methods
within an analytical chain consisting of sample prepar-
ation, target extraction, purification and, finally, detec-
tion. What concludes from recognition of the analytical
chain is that a reliable and controllable method for each
of these steps has to be chosen and examined, because
if any of those methods fails, a false negative result
is inevitable.
Although it is a definitive bottleneck for the whole
analytical chain, sample preparation has not received as
much attention in the past as it deserves. However, this
is expected to change. Current efforts in sample prepar-
ation [25] and molecular enrichment [28] have demon-
strated simple solutions for concentrating and recovering
microorganisms. In this study we present Matrix-Lysis,
which breaks up cell membranes and solubilizes the tissue
matrix, thereby additionally permitting detection of intra-
cellular bacteria. This is an important issue in clinical
diagnostics, whereby a possible dissemination of patho-
genic bacteria can be monitored.
In this study, for every tissue tested, more than one
effective lysis strategy could be found. Lung tissue was
an exception; only the 2 M MgCl2 + 1% Lutensol lysis
buffer permitted an adequate resultant pellet size forfurther analysis. When aiming for results based on
PCM, 2 M MgCl2 should be used. However, it must be
recognized that lysis efficiency is highly dependent upon
the anatomical organ and on any pathological changes
than may have taken place. If pathological changes can
be diagnosed, this is most commonly associated with
changes in tissue composition or structure. The lysis
buffer strategy should then be adapted accordingly. It is
advisable to perform a process control for each experi-
ment as suggested in [15], as recovery rates of target
cells can be influenced by tissue changes.
Until now, prior to plating, an enrichment step has
been necessary for detection of bacteria from tissues that
do not readily permit target cell quantification [17]. The
results of this study demonstrate that plating of bacteria
and reliable quantification becomes possible implemen-
tation of a tissue preparation method that protects
cultivable bacteria. With Matrix-Lysis, using the MgCl2
lysis buffer without detergent, the matrix size is reduced
and targets are concentrated. We have shown that quan-
tification of very low target cells, even a single cell, is
reliable and reproducible using Matrix-Lysis for tissue
preparation and the PCM method for quantification.
The constant mean recovery rate over the dilution
series after PCM (96.1%; R2 = 0.99) revealed excellent
stability of the method, independent of the target quantity.
This offers new and promising strategies for quantitative
plating approaches in analytical veterinary diagnostics.
Matrix-Lysis, followed by quantification with qPCR, can
produce the same mean recovery rates as published before
using Matrix-Lysis for food matrices [25-27]. Processed
kidney tissue was associated with lower recovery rates
(15% ± 7.9%), even although kidney tissue resulted in a
small pellet (<350 μg) after Matrix-Lysis and background
DNA in the pellet was similar to that obtained from other
organs (data not shown). This may suggest that the lower
recovery rate is consequential to inadequate removal of
Figure 1 Matrix-Lysis protocol adapted for clinical tissue. This includes timeline and subsequent target detection paths. *The protocol is designed
for a maximum of 5 g of tissue. The tissue must be cut into small pieces (Ø <4 mm2). **Homogenization of tissue in 8 M urea + 1% SDS takes place at an
incubation temperature of 42°C; an incubation temperature of 37°C is recommended for 2 M MgCl2 (±1% Lutensol).
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of kidney tissue will be examined further.
Spiking experiments with cerebrum over the whole
dilution series resulted in a very high coefficient of de-
termination (R2 = 0.99). For the lysis buffers based on
8 M urea + 1% SDS and 2 M MgCl2 + 1% Lutensol, con-
stant recovery down to 349 BCE/g and 406 BCE/g,
respectively, could be achieved with qPCR. As shown in
this study, the newly developed Matrix-Lysis tissue prep-
aration method is capable of recovering and concentrat-
ing single bacterial cells from as much as 5 g of tissue
sample, efficiently and robustly.
Nevertheless, the discrepancy between the LOD of one
cell with PCM compared to that of 102 cells with qPCR
has to be discussed. Firstly, most qPCR approaches useonly a small fraction (commonly between 1/20 – 1/40;
this study 1/20) of the sample eluate after DNA-
extraction, which inevitably increases the overall detec-
tion limit [28]. Secondly, it is well known that common
DNA purification procedures are not highly efficient at
recovering target DNA at low concentrations from a
high amount of background DNA; which may also lead
to an increase in the LOD [28]. Finally, in this study only
1/2 of the B3 buffer lysate (part of the DNA extraction
system used) was taken for DNA extraction when quan-
tifying with qPCR. The reason for this was the remaining
tissue DNA in the pellet. Although Matrix-Lysis reduced
5 log units of free DNA from the sample [26], the col-
umn of DNA extraction was overloaded with DNA from
the remaining pellet after Matrix-Lysis. This leads to an
Figure 2 Recovery of L. monocytogenes (BCE/g) after Matrix-Lysis from nine different clinical tissues. The spike control represents the
initial number of BCE/g that was used for spiking clinical tissues. The lysis buffer based on 2 M MgCl2 + 1% Lutensol was used for Matrix-Lysis.
Bars indicate standard deviations.
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amount of the B3 buffer lysate (part of the DNA extrac-
tion system used) can easily circumvent this limitation,
but it increases the detection limit.
Additional file 1: Figure S1 depicts the decrease in tar-
get copy detection with more than 70 μg of background
DNA in the DNA extraction system. Background DNA
content of the Matrix-Lysis pellets was approximately
200–400 μg.
If only qualitative results are required, novel approaches,
such as molecular enrichment, can circumvent theseTable 2 LOD determination of Matrix-Lysis tissue
preparation using plate count method (PCM) for
enumeration from 5 g of cerebral tissue
CFU1 control2 CFU per plate after ML3 Sum of CFU after ML
51 ± 3 21, 9, 11, 5, 11 57
4.5 ± 0.5 2, 0, 1, 1, 0 4
0.5 ± 0.5 1, 0, 0, 0, 0 1
18 ± 1 2, 10, 5, 10, 4 31
0.5 ± 0.5 0, 1, 0, 0, 0 1
0 ± 0 0, 0, 0, 0, 0 0
20 ± 5 4, 5, 7, 4, 1 21
1 ± 0 0, 3, 0, 0, 0 3
0 ± 0 0, 0, 0, 0, 0 0
1CFU: Colony forming units.
2PCM was used prior to Matrix-Lysis on TSA + Y for the spiking control.
3Recovery rates after Matrix-Lysis were determined by subdividing the remaining
pellet into five equal parts and plating them individually onto ALOA agar.limitations [28] and this is an important methodological
consideration when using qPCR in the future. However,
this was not applied in this study. If there is a goal for
future detection limits as low as ~100 BCE/5 g, these re-
sults also highlight the urgent need for more efficient and
robust DNA-extraction and concentration methods.
As previously indicated, DNA-extraction is an import-
ant bottleneck step for qPCR-based quantification and
from the results of this study we suggest the application
of internal cellular-based extraction controls, to control
for inefficient extraction and purification [17]. Never-
theless, the detection limits achieved with Matrix-Lysis
and qPCR are as good as the quantification limits asso-
ciated with high-technology methods, such as fiber
optic immunosensors coupled with immunomagnetic
separation or antibody-based immunosensors [29,30].
To our knowledge, Matrix-Lysis is the only economical
and easy-to-use tissue preparation method that can
compete with these novel high-technology methods,
considering the LOD and coefficients of determination
in whole dilution series.
Conclusions
In summary, it can be concluded that the Matrix-Lysis
protocol from food science can be successfully adapted
to clinical tissues. To our knowledge this is the first
study presenting an easy-to-use and economical tissue
preparation method for routine use and analytical veter-
inary diagnostics. The tissue preparation method permits
quantification of pathogens from 5 g samples of organic
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sample preparation methods. Following Matrix-Lysis,
the remaining pellet contains the total bacterial population
of the sample. This pellet can then be further processed
with DNA-based quantification or plating methods. It can
be used for clinical research and diagnostic monitoring.
For example, enumeration of lactobacilli and other Gram-
positives can be useful for studying effects of dietary
manipulations in pigs [31] or pathogen quantification
can be used to support inoculation studies (e.g. vaccine
testing). Hazard assessments and slaughterhouse prac-
tices will strongly profit from this reliable tissue prepar-
ation method and it is anticipated that this study will




Cerebrum, spinal cord, lung, liver, ileum, colon, caecum,
kidney and muscle tissues were obtained from slaugh-
tered pig carcasses from a slaughterhouse in lower
Austria and from tissue provided from the Clinic for
Swine, University of Veterinary Medicine, Vienna. No
animals were euthanized for the purposes of this re-
search. Exact anatomic sampling sites are listed in
Table 3. The tissues were cut into 5 g pieces and
inserted into 50 ml polypropylene tubes for storage
(Cornig, NY, USA). All tubes were cooled during trans-
port and stored at −20°C.
Culture of Listeria monocytogenes EGDe
L. monocytogenes (1/2a, internal number 2964) was con-
served at −80°C using MicroBank technology (Pro-Lab
Diagnostics, Richmond Hill, Ontario, Canada) and con-
stituted part of the collection of bacterial strains kept by
the Institute of Milk Hygiene, University of Veterinary
Medicine, Vienna. L. monocytogenes was incubated over-
night (37°C) in tryptone soy broth (TSB) with 0.6% (w/v)
yeast extract (Oxoid, Basingstoke, Hampshire, UK).Table 3 Animal tissues and precise anatomical sampling
locations for all tissues used in this study
Tissue Sampling location
Cerebrum Substantia grisea and Substantia alba
Spinal cord Pars cervicalis
Liver Lobus hepatis dexter lateralis
Colon Colon ascendens
Kidney Border medulla - Cortex
Lung Right lung: Lobus medius, Lobus caudalis
Ileum Terminal ileum, sparing Plica ileocaecalis
Caecum Apex caeci
Muscle Cervical musculatureSpiking of clinical tissues and experimental controls
For artificial contamination of tissues a 1 ml aliquot was
taken from the overnight culture, placed into fresh TSB
and directly incubated at 37°C for another three hours.
Subsequently, a ten-fold dilution series was prepared
using phosphate buffered saline (PBS) as diluent. The
amount of inocula (100 μl) for spiking dilution series using
cerebral tissue ranged from approximately 101- 106 BCE
or respectively CFU. For the spiking trial of nine different
tissues, a target concentration of approximately 105 BCE/g
was used. Ice-cold tissues were cut into small pieces
(Ø <4 mm2) and spiked with pipetted droplets of cul-
ture of known concentration. Tissues were processed
immediately. All spiking experiments and determination
of the LOD were performed in triplicate. All organs used
for artificial contamination experiments were tested to be
negative for L. monocytogenes prior to inoculation using
the Matrix-Lysis protocol and the real-time PCR assay
described by Rossmanith et al. [32].
All spiking experiments were controlled by three
methods: using the plate count method (PCM), micro-
scopic enumeration and a qPCR step to check for pos-
sible discrepancies between the different enumeration
techniques. Tryptone soy agar plates, supplemented with
0.6% (w/v) yeast extract (TSAYE; Oxoid), were used for
the PCM. Dilution series of the cultures were plated and
incubated at 37°C for 24 hours. Microscopic investiga-
tion was performed with 500 μl of an appropriate dilu-
tion of bacteria, following the protocol provided in the
Live/Dead® BacLight kit (Molecular Probes, Willow Creek,
OR, USA). Samples were analyzed using a Laborlux 8
fluorescence microscope (Leitz, Wetzlar, Germany) with a
470 nm filter and a 1,000-fold optical magnification. Two
filters were analyzed per sample and fifteen visual fields
were counted per filter. The following formula was used
for calculation of the number of stained bacteria per milli-
liter: mean bacterial count in one field X (filtration area
size/field size) X (1/dilution factor × 0.5 ml).
Matrix-Lysis protocol and its adaptation to tissue matrices
The solubilizing ability of different buffer systems was
examined for testing the applicability of Matrix-Lysis on
clinical tissues. Matrix-Lysis buffers (sucrose + protease
buffer, lysing buffer 8 M urea + 1% SDS, washing buffer)
were prepared as previously described [26]. Matrix-Lysis
buffers based on magnesium chloride comprised 2 M
MgCl2, 50 mM Tricine and optionally 1% Lutensol AO-
07 and a pH adjusted to 7.0 (P. Mester, personal com-
munication). All reagents for the Matrix-Lysis protocol
were purchased from Merck (Darmstadt, Germany),
with the exception of SDS, Tricine (Sigma-Aldrich,
Steinheim, Germany), Lutensol AO-07 (BASF, Arnheim,
Netherlands) and Savinase (Novozymes, Krogshoejvev,
Denmark).
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using the lysis buffer 8 M urea + 1% SDS, and both vari-
ants of MgCl2 lysis buffers, with and without 1% Luten-
sol. The Matrix-Lysis protocol previously published [26]
was followed. After determining the resultant pellet size
of different tissues after the Matrix-Lysis preparation step,
the protocol was adapted for optimum solubilization of
clinical tissue. The adapted protocol included five
grams of clinical tissue that were cut into small pieces
(Ø <4 mm2) and homogenized with the Stomacher 400
blender (Steward, London, UK) in 25 ml of sucrose-
protease buffer for ten minutes. The homogenate was
transferred to a sterile 50 ml polypropylene tube (Cornig,
NY, USA) and incubated in a water bath at 37°C shaken at
250 rpm for 30 minutes. Samples were then centrifuged at
3,220 × g at room temperature for 30 minutes. The super-
natant was decanted and the pellet resuspended in 30 ml
lysis buffer. Samples were then incubated in a water bath
at 37°C (lysis buffer based on MgCl2) or 42°C (lysis buffer
based on urea) and shaken at 250 rpm. Subsequently,
samples were re-homogenized for ten minutes. Resultant
sample homogenates were then made up to 45 ml with
lysis buffer and vortexed rigorously. Diluted homogenates
were centrifuged at 3,220 × g for 30 minutes at room
temperature. Supernatants were decanted and pellets
resuspended in 40 ml of washing buffer. Samples were
then incubated in a water bath for 30 minutes (shaken at
250 rpm), at the same temperature used during incubation
in lysis buffer. Incubated samples were next centrifuged
at 3,220 × g for 30 minutes at room temperature and
the supernatant decanted. Pellets were resuspended in
1,500 μl PBS and transferred to a 2 ml plastic tube
(Eppendorf, Hamburg, Germany). Pellets were washed
twice using 1,500 μl PBS in centrifugation steps (5 minutes,
8,000 × g). The adapted protocol is shown in Figure 1. All
buffers (protease buffer, lysis buffer and washing buffer)
were pre-warmed before use and all experiments were
performed in triplicate.Plating, DNA extraction and qPCR
For quantification of L. monocytogenes in clinical tissues
after Matrix-Lysis, the remaining pellet was either plated
onto selective agar plates for viable cell quantification or
DNA extraction was performed for subsequent qPCR
enumeration. The PCM was used for viable cell quantifi-
cation. The remaining pellet from Matrix-Lysis was
resuspended in PBS to achieve a total volume of one ml
and rigorously vortexed until homogenized. 100 μl
aliquots of a ten-fold dilution series were plated onto
selective ALOA agar (Biolife, Milan, Italy). DNA extrac-
tion was performed with the NucleoSpin® tissue kit
(Machery-Nagel, Düren, Germany) using the protocol
for Gram-positive bacteria.Since somatic cells remain in the Matrix-Lysis pellet
and result in high background DNA levels and overload
of the DNA extraction column, only 1/2 of the B3 buffer
lysate was used for further DNA extraction. Following
extraction, qPCR quantification of L. monocytogenes was
performed by targeting a fragment of the prfA gene
(274 bp) [32,33]. A DNA standard containing 1 ng/μl of
L. monocytogenes DNA and a derivative 4 log10 dilution
series were used as calibration standards for each run.
The qPCR reaction on 25 μl samples was performed in a
Mx3000p qCR termocycler (Stratagene; La Jolla, CA,
USA) in duplicate using 5 μl of DNA template.
Supplementary Information accompanies the paper
on the BMC Veterinary Research Journal website
(http://biomedcentral.com).
Additional file
Additional file 1: Figure S1. Influence of background DNA concentration
on DNA extraction efficiency. 30–300 μg of salmon sperm-DNA was
added to the DNA extraction system to determine changes in quantification
efficiency in the presence of background DNA.
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